First-in-class multifunctional TYMS nonclassical antifolate inhibitor with potent in vivo activity that prolongs survival.
Guijarro MV, Kellish PC, Dib PE, Paciaroni NG, Nawab A, Andring J, Kulemina L, Borrero NV, Modenutti C, Feely M, Nasri E, Seifert RP, Luo X, Bennett RL, Shabashvili D, Licht JD, McKenna R, Roitberg A, Huigens RW 3rd, Kaye FJ, Zajac-Kaye M.
Guijarro MV, et al. Among authors: huigens rw 3rd.
JCI Insight. 2023 Apr 25;8(10):e158798. doi: 10.1172/jci.insight.158798.
JCI Insight. 2023.
PMID: 37097751
Free PMC article.